Browse Topic
Research
-
September 25, 2023UC Davis developing models to predict the excitability of brain neuronal circuits
Researcher Roy Ben-Shalom is developing a model that simulates changes in neuronal activity caused by ion channel mutations to select the most effective therapy for many neurodevelopmental conditions.
Read More -
September 20, 2023First Wilson Disease patient receives gene therapy at UC Davis Health
Researchers have infused their first Wilson Disease patient with a gene therapy which has the potential to treat the underlying cause of the disease.
Read More -
September 18, 2023Engineered bone marrow shows promise as cancer treatment
The development of engineered bone marrow is revolutionizing research and treatment for osteosarcoma, the most common malignant bone cancer in children.
Read More -
September 18, 2023Neck pain? The provider you see first affects tests, imaging and follow-up care
The specialist you see first for your neck pain has a big impact on how your condition gets diagnosed and treated, a UC Davis study has found
Read More -
September 13, 2023Record external funding supports UC Davis School of Medicine research
UC Davis exceeded $1 billion in external research funding in the fiscal year 2022–23. The School of Medicine contributed 40% of this amount, achieving a new research funding record.
Read More -
September 13, 2023This postpartum contraception is more effective than condoms or birth control pills
A new UC Davis Health study examined women’s understanding of lactational amenorrhea, the period of temporary infertility that accompanies exclusive breastfeeding.
Read More -
September 08, 2023National Cancer Institute awards UC Davis hematologist a prestigious research grant
UC Davis hematologist Brian Jonas awarded the National Cancer Institute Research Specialist Award (R50) to further his leadership in NCI-funded cancer research.
Read More -
September 06, 2023New study spotlights radiation exposure from medical imaging for children with Down syndrome
Down syndrome can mean more X-rays — and more radiation exposure — for children already at increased risk of cancer.
Read More -
September 01, 2023Software developed at UC Davis analyzes calcium ‘sparks’ that can contribute to arrhythmia
UC Davis and the University of Oxford researchers developed a new software tool, SparkMaster 2, that allows scientists to analyze normal and abnormal calcium activity in cells.
Read More
-
August 29, 2023MIND Institute director calls for new approach to equity in autism, fragile X research
MIND Institute Director Leonard Abbeduto has co-authored a paper in the American Journal on Intellectual and Developmental Disabilities that calls for a paradigm shift in disability research.
Read More -
August 29, 2023Eye Center tests experimental gene therapy for wet age-related macular degeneration
An experimental medicine being tested at the UC Davis Eye Center uses gene therapy as a possible treatment for wet age-related macular degeneration or wet AMD.
Read More -
August 25, 2023UC Davis explores emergency-primary care team partnership to improve opioid treatment
UC Davis clinicians are developing a multiteam strategy to boost rates of long-term use of buprenorphine among patients who seek care for opioid use disorder in emergency departments.
Read More -
August 25, 2023Cancer center researcher awarded grant to study lethal cancers in firefighters
Research at UC Davis to uncover the potential causes of cancer in firefighters is getting a boost from a California climate action grant.
Read More -
August 24, 2023Gene therapy study identifies potential new treatment for liver cancer
Gene therapy with microRNA-22 produced better survival outcomes than the current FDA-approved drug for liver cancer and without noticeable toxicity in new mouse study.
Read More -
August 24, 2023Neurosurgeon receives national recognition for research on spinal cord injury
The Congress of Neurological Surgeons has named a paper by UC Davis Health neurosurgeon Kee Kim as the "2023 Top Spine Paper of the Year.”
Read More -
August 22, 2023UC Davis Health and Kennedy Krieger Institute work to predict mental health issues after concussion
Researchers at UC Davis Health and Kennedy Krieger Institute have received a grant to develop a clinical tool to predict mental health concerns in adolescents following a concussion.
Read More -
August 21, 2023MIND Institute gets $4.7 million NIMH grant to test autism intervention in community
Researchers in the Department of Psychiatry and Behavioral Sciences and the MIND Institute have received $4.7 million from the National Institute of Mental Health to test a child-focused autism intervention with community partners.
Read More -
August 18, 2023UC Davis first in the state to offer life-changing therapy for Duchenne Muscular Dystrophy
A 5-year-old boy diagnosed with Duchenne muscular dystrophy is the first in California and fourth in the nation to receive groundbreaking gene therapy outside of clinical trials.
Read More -
August 10, 2023Cancer researcher gets federal funding to test immunotherapy in drug-resistant prostate cancer
UC Davis Comprehensive Cancer Center scientist receives $1.4 million federal grant to boost efforts finding a breakthrough treatment for late stage, drug-resistant prostate cancer.
Read More -
August 08, 2023Canine Tumor Genome Atlas maps DNA in pets to help people with cancer
Cancer center launches joint research data bank with UC Davis School of Veterinary Medicine. Samples collected from pets with cancer may help unlock the mystery of cancer in people.
Read More -
August 03, 2023Study finds new treatment for pulmonary hypertension holds promise
A study led by the Goncharova Lab has validated a potential therapeutic option to treat pulmonary arterial hypertension, a condition that currently lacks effective treatments.
Read More -
August 01, 2023
Betty Irene Moore Fellows gather at UC Davis nursing school for fourth annual convocation
The 2023 Convocation marked largest ever gathering of fellows, national advisory council members, nurse leaders and program faculty.
Read More
-
July 31, 2023National kidney cancer study shows promising results
Results from a national clinical trial testing a new anti-cancer drug show that people with kidney cancer lived longer after taking the therapy following surgery.
Read More -
July 21, 2023COVID-19 can cause inflammation that results in bone loss, higher fracture risk
A new study involving mice suggests that patients with COVID‐19 may experience long‐term orthopedic issues, such as decreased bone mass, increased fracture risk, and other musculoskeletal complications.
Read More -
July 20, 2023
Volunteering in late life may protect the brain against cognitive decline and dementia
Volunteering in late life is associated with better cognitive function — specifically, better executive function and episodic memory, according to a new UC Davis study.
Read More -
July 19, 2023Cancer center gets its own ‘hugabox collection’
Helping raise money for sarcoma research is now easier (and more fun) with the new UC Davis Comprehensive Cancer Center “hugabox collection.”
Read More -
July 18, 2023NIH renews MIND Institute grant to study fragile X-associated syndromes for 24th year
This fragile X awareness month, the NIH has renewed funding for a key study of the neurodegenerative condition fragile X-associated tremor ataxia syndrome (FXTAS).
Read More -
July 14, 2023UC Davis Health is advancing tobacco treatment for Medi-Cal members
UC Davis Health received a CA Quits grant and a TRDRP research award that would help support initiatives and resources for people to stop smoking.
Read More -
July 03, 2023Esteemed UC Davis translational researcher captures top award
A novel pancreatic cancer clinical trial at UC Davis Comprehensive Cancer Center is achieving critical acclaim within the nuclear medicine industry.
Read More
-
June 28, 2023Landmark NCI grant bolsters UC Davis cancer health equity research
UC Davis researchers join colleagues at Stanford and UCSF to study how helping people rise above persistent poverty may help prevent cancer.
Read More
